{
  "input": {
    "mode": "build_chain",
    "query": {
      "entity": "Neonatal cholestasis",
      "relation": "contraindication"
    },
    "hypotheses": [
      {
        "id": "H1",
        "candidate": {
          "id": "drug_cholestyramine",
          "name": "Cholestyramine"
        },
        "mechanism_outline": "",
        "priority": 1.0
      },
      {
        "id": "H2",
        "candidate": {
          "id": "drug_phenobarbital",
          "name": "Phenobarbital"
        },
        "mechanism_outline": "",
        "priority": 0.95
      },
      {
        "id": "H3",
        "candidate": {
          "id": "drug_sodium_phenylbutyrate",
          "name": "Sodium phenylbutyrate"
        },
        "mechanism_outline": "",
        "priority": 0.9
      },
      {
        "id": "H4",
        "candidate": {
          "id": "drug_n_acetylcysteine",
          "name": "N-acetylcysteine"
        },
        "mechanism_outline": "",
        "priority": 0.85
      },
      {
        "id": "H5",
        "candidate": {
          "id": "drug_ciprofloxacin",
          "name": "Ciprofloxacin"
        },
        "mechanism_outline": "",
        "priority": 0.8
      },
      {
        "id": "H6",
        "candidate": {
          "id": "drug_rifampin",
          "name": "Rifampin"
        },
        "mechanism_outline": "",
        "priority": 0.75
      },
      {
        "id": "H7",
        "candidate": {
          "id": "drug_erythromycin",
          "name": "Erythromycin"
        },
        "mechanism_outline": "",
        "priority": 0.7
      },
      {
        "id": "H8",
        "candidate": {
          "id": "drug_amiodarone",
          "name": "Amiodarone"
        },
        "mechanism_outline": "",
        "priority": 0.6499999999999999
      },
      {
        "id": "H9",
        "candidate": {
          "id": "drug_sodium_valproate",
          "name": "Sodium valproate"
        },
        "mechanism_outline": "",
        "priority": 0.6
      },
      {
        "id": "H10",
        "candidate": {
          "id": "drug_tetracycline",
          "name": "Tetracycline"
        },
        "mechanism_outline": "",
        "priority": 0.55
      },
      {
        "id": "H11",
        "candidate": {
          "id": "drug_fluconazole",
          "name": "Fluconazole"
        },
        "mechanism_outline": "",
        "priority": 0.5
      },
      {
        "id": "H12",
        "candidate": {
          "id": "drug_atorvastatin",
          "name": "Atorvastatin"
        },
        "mechanism_outline": "",
        "priority": 0.44999999999999996
      }
    ],
    "tegraph_snapshot": {
      "nodes": [],
      "edges": [],
      "round_index": 1
    },
    "constraints": {
      "require_disjoint_paths": 2,
      "max_new_nodes": 50,
      "max_new_edges": 64,
      "batched": true
    },
    "ablation_config": {
      "enable_debate": true,
      "enable_skeptic": true,
      "enable_pi_interrupts": true,
      "enable_textual_feedback": true,
      "enable_heuristic_transfer": true,
      "enable_seed_regen": true,
      "weights": {
        "path_disjointness": 1.0
      },
      "mode": "graph"
    }
  },
  "output": {
    "graph_updates": {
      "add_nodes": [
        {
          "id": "n_target_abcb4",
          "type": "Target",
          "label": "ABCB4",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_pathway_bile_acid_metabolism",
          "type": "Pathway",
          "label": "Bile Acid Metabolism",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_disease_neonatal_cholestasis",
          "type": "Disease",
          "label": "Neonatal Cholestasis",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_phenotype_biliary_clearance",
          "type": "Phenotype",
          "label": "Biliary Clearance Impairment",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_target_cyp3a4",
          "type": "Target",
          "label": "CYP3A4",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_pathway_liver_metabolism",
          "type": "Pathway",
          "label": "Liver Drug Metabolism",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_target_uptake_transporters",
          "type": "Target",
          "label": "Uptake Transporters",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_pathway_excretion",
          "type": "Pathway",
          "label": "Excretion Pathways",
          "attrs": {
            "agent": "Proponent"
          }
        }
      ],
      "add_edges": [
        {
          "source": "drug_cholestyramine",
          "target": "n_target_abcb4",
          "relation": "acts_on",
          "weight": 0.85,
          "agent": "Proponent",
          "rationale": "根据相关药理机制作用于胆盐转运蛋白"
        },
        {
          "source": "drug_cholestyramine",
          "target": "n_pathway_bile_acid_metabolism",
          "relation": "involved_in",
          "weight": 0.75,
          "agent": "Proponent",
          "rationale": "与胆道代谢通路相关"
        },
        {
          "source": "n_target_abcb4",
          "target": "n_disease_neonatal_cholestasis",
          "relation": "causes",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "对新生儿胆汁淤积症相关靶点的影响"
        },
        {
          "source": "n_pathway_bile_acid_metabolism",
          "target": "n_phenotype_biliary_clearance",
          "relation": "causes",
          "weight": 0.7,
          "agent": "Proponent",
          "rationale": "干扰胆汁排泄导致表型改变"
        },
        {
          "source": "drug_phenobarbital",
          "target": "n_target_cyp3a4",
          "relation": "acts_on",
          "weight": 0.85,
          "agent": "Proponent",
          "rationale": "促进CYP3A4酶活性"
        },
        {
          "source": "n_target_cyp3a4",
          "target": "n_pathway_liver_metabolism",
          "relation": "involved_in",
          "weight": 0.7,
          "agent": "Proponent",
          "rationale": "对肝脏药物代谢的影响"
        },
        {
          "source": "drug_sodium_phenylbutyrate",
          "target": "n_target_uptake_transporters",
          "relation": "acts_on",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "影响药物摄取运输通路"
        },
        {
          "source": "n_target_uptake_transporters",
          "target": "n_pathway_excretion",
          "relation": "involved_in",
          "weight": 0.75,
          "agent": "Proponent",
          "rationale": "与排泄途径相关联"
        },
        {
          "source": "n_pathway_excretion",
          "target": "n_disease_neonatal_cholestasis",
          "relation": "causes",
          "weight": 0.7,
          "agent": "Proponent",
          "rationale": "影响胆汁流动对疾病的影响"
        },
        {
          "source": "n_pathway_liver_metabolism",
          "target": "n_disease_neonatal_cholestasis",
          "relation": "causes",
          "weight": 0.65,
          "agent": "Proponent",
          "rationale": "通过肝脏代谢改变影响疾病发展"
        },
        {
          "source": "drug_n_acetylcysteine",
          "target": "n_target_cyp3a4",
          "relation": "acts_on",
          "weight": 0.65,
          "agent": "Proponent",
          "rationale": "潜在调节CYP3A4活性"
        },
        {
          "source": "drug_ciprofloxacin",
          "target": "n_target_abcb4",
          "relation": "acts_on",
          "weight": 0.6,
          "agent": "Proponent",
          "rationale": "具有类似胆盐转运影响"
        },
        {
          "source": "drug_rifampin",
          "target": "n_target_cyp3a4",
          "relation": "acts_on",
          "weight": 0.6,
          "agent": "Proponent",
          "rationale": "已知对肝脏酶有影响"
        },
        {
          "source": "drug_erythromycin",
          "target": "n_target_uptake_transporters",
          "relation": "acts_on",
          "weight": 0.55,
          "agent": "Proponent",
          "rationale": "可能影响药物摄取通路"
        },
        {
          "source": "drug_amiodarone",
          "target": "n_pathway_liver_metabolism",
          "relation": "involved_in",
          "weight": 0.5,
          "agent": "Proponent",
          "rationale": "对肝脏药物代谢的影响"
        },
        {
          "source": "drug_sodium_valproate",
          "target": "n_target_abcb4",
          "relation": "acts_on",
          "weight": 0.45,
          "agent": "Proponent",
          "rationale": "有潜在影响胆盐转运的作用"
        },
        {
          "source": "drug_tetracycline",
          "target": "n_target_uptake_transporters",
          "relation": "acts_on",
          "weight": 0.4,
          "agent": "Proponent",
          "rationale": "可能干扰摄取通路"
        },
        {
          "source": "drug_fluconazole",
          "target": "n_pathway_bile_acid_metabolism",
          "relation": "involved_in",
          "weight": 0.4,
          "agent": "Proponent",
          "rationale": "有助于胆盐代谢"
        },
        {
          "source": "drug_atorvastatin",
          "target": "n_target_cyp3a4",
          "relation": "acts_on",
          "weight": 0.35,
          "agent": "Proponent",
          "rationale": "对CYP3A4的潜在影响"
        },
        {
          "source": "n_phenotype_biliary_clearance",
          "target": "H1",
          "relation": "supports",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "通过相关机制支持假设H1的成立"
        },
        {
          "source": "n_phenotype_biliary_clearance",
          "target": "H2",
          "relation": "supports",
          "weight": 0.75,
          "agent": "Proponent",
          "rationale": "影响胆汁清除的潜在机制支持H2"
        },
        {
          "source": "n_phenotype_biliary_clearance",
          "target": "H3",
          "relation": "supports",
          "weight": 0.73,
          "agent": "Proponent",
          "rationale": "影响胆汁清除对H3的支持"
        },
        {
          "source": "n_phenotype_biliary_clearance",
          "target": "H4",
          "relation": "supports",
          "weight": 0.7,
          "agent": "Proponent",
          "rationale": "对H4的支持与影响清除表型有关"
        }
      ],
      "merge": [],
      "set_weights": []
    },
    "subconclusions": [
      {
        "id": "C1",
        "text": "不同药物通过影响胆道代谢和清除路径可能关联新生儿胆汁淤积症",
        "confidence": "medium"
      },
      {
        "id": "C2",
        "text": "Cholestyramine与胆盐转运相关机制支持其在新生儿胆汁淤积症中的作用假设",
        "confidence": "medium"
      }
    ],
    "assumptions": [
      "上述药物具备最小可到达靶器官的暴露量"
    ],
    "uncertainties": [
      "不同药物的潜在不良反应需要进一步确认"
    ],
    "next_focus_for_pi": [
      "需要评估所有药物的安全性与相互作用"
    ]
  }
}